Mark Thomas, PhD, neuroscientist and scientific director for the U of M Medical Discovery Team (MDT) on Addiction, believes researchers have an obligation to talk with the public about the societal challenges of addiction.
A new cancer treatment therapy is being tested for the first time in patients at the M Health Fairview University of Minnesota Medical Center.
New study opens at the University of Minnesota’s Center for Pediatric Obesity Medicine.
Researchers have discovered how to clear zombie cells, so many companies are now developing drugs to remove the cells, with the hope of people leading healthier, longer lives.
The National Institute of Mental Health awarded $740K to Michael-Paul Schallmo, PhD, who will study the differences in visual context among people diagnosed with schizophrenia.
Sonya Wang, MD, received a National Institutes of Health grant to research the effects of music-based intervention (MBI) on neurodevelopment and pain response in preterm infants.
Research conducted by John Wagner, MD, and Margaret MacMillan, MD, has not only helped make BMT possible but also contributed to a 90% survival rate. This has led to success stories like Kyle Tanner’s.
The new study examines why some infected cells evaded T cell-mediated killing in the lungs of a mouse model.
Dr. Vinogradov focuses on psychotic disorders where individuals experience abnormal thinking and perceptions.
Brian M. Sweis, PhD, is the first student in the Medical School’s history to receive the prestigious Donald B. Lindsley Prize in Behavioral Neuroscience by the Society for Neuroscience.